Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tiotropium Test vs Reference Products
NCT02627625Phase 1Completed
- Sponsor
- Solventum
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) and asthma (5 arms), sponsored by Solventum. Primary endpoint: Peak Plasma Concentration at 8 hours. Started Nov 2015; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT02627625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02627625.